Tarsus Advances Eye Care Leadership Strategy with Acquisition of iRenix Medical and Late-Stage Asset IRX-101

IRX-101 targets a significant need for millions of patients facing vision loss and has the potential to improve the standard of carePositive ...
MarketBeat on MSN

Tarsus Pharmaceuticals enters retina market with iRenix deal, adds IRX-101 to pipeline

Key Points Interested in Tarsus Pharmaceuticals, Inc.? Here are five stocks we like better. Tarsus Pharmaceuticals closed its ...

Tarsus buys iRenix in deal worth up to $565 million, adds late-stage eye drug

Tarsus Pharmaceuticals Inc. TARS on Wednesday acquired privately held iRenix Medical Inc., adding late-stage investigational ...

Ecolab: Data Center Growth Insufficient To Support 33x P/E Ratio

Ecolab's high-tech/data center vertical offers long-term potential, but current contributions are modest and require ...

Is chlorination the most effective method of water disinfection?

Water contaminants span a wide range of biological and chemical agents, which makes effective wastewater treatment essential ...